1Qian ZM,Li H,Sun H,et al.Targeted drag delivery via the transfer-rin receptor-mediated endocytosis Pathway[J].Pharmacol Rev,2002,54(4):561-587.
2Leplletier Y,Camara-Clayette V,Jin H,et al.Prevemion of mantle-lymphoma tumor establishment by routing transferrin receptor toward lysosomal compartments[J].Cancer Res,2007,67(3):1145-1154.
3Daniel TR,Delgado T,Rodriguez JA,et al.The transferrin receptor parti:biology and targeting with cytotoxic antibodies for the treatment of cancer[J].Clin Immunal,2006,121(2):144-158.
4Kawabata H,Yang R,Hirama T,et al.Molecular cloning of transferrin receptor 2.A new member of the transferrin receptor-like family[J].Boil Chem,1999,274(30):20826-20832.
5Kawabata H,Gemtain RS,Vuong PT,et al.Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo[J].Biol Chem,2000,275(22):16618-16625.
6Kawabata H,Gemtain RS,Ikczoe T.Regulation of expression of murine transferrin receptor 2[J].Blood,2001,98(6):1949-1954.
7Ponka P,Lok CN.The transferring receptor role in health and disease[J].Biochem Cell Biol,1999,31:1111-1137.
8Giannetti AM,Snow PM,Zak O,et al.Mechanism for multiple li-gand recognition by the human transferring receptor[J].PLo S Biol,2005,1:51.
9Gomme PT,McCann KB,Bertolini J.Transferrin:structure,function and potential therapeutic actions[J].Drug Discovery Today,2005,10:267.
10Pandey KN.Functional roles of short sequence motifs in the endocytosis of membrane receptors[J].Front Biosci,2009,14:5339-5360.
3Moghrabi A, Levy DE, Asselin B, et al. Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood, 2007,109 (3) :896-904.
4Danuta SK, Richardson R. The evolution of iron chelators for the treatment of iron overload disease and cancer. Pharmacol Rev, 2005,57(4):547-583.
5Kawabata H, Germaln RS, Ikezoe X, et al. Regulation of expression of murine transferrin receptor 2. Blood, 2001,98 (6):1949-1954.
6Calzolari A, Oliviero I, Deaglio S, et al. Transferrin receptor 2 is frequently expressed in human cancer cell lines. Blood Cells Mol Dis,2007,39(1) :82-91.
7Kollia P, Samata M, Stamatopoulos K, et al. Molecular for transferrin receptor 2 expression in all FAB subtypes of acute myeloid leukemia. Leuk Res,2003 ;27(12) : 1101-1103.
8Nakamaki T, Kawabata H, Saito B, et al. Elevated levels of transferrin receptor 2 mRNA, not transferrin receptor 1 mRNA, are associated with increased survival in acute myeloid leukemia. B J Heamatol,2004,125(1) :42-49.
9Kawabata H, Yang R, Hirama T, et al. Molecular cloning of transferrin receptor 2 : a new member of the transferrln receptor-like family. J Biol Chem,1999,274(30) :20826-20832.
10Girelli D, Bozzini C, Roetto A, et al. Clinical and pathologic findings in hemochromatosls type 3 due to a novel mutation in transferrin receptor 2 gene. Gastroenterology, 2002 ; 122 (5) : 1295-1302.
